168 related articles for article (PubMed ID: 19637187)
1. Abnormal hepatic energy homeostasis in type 2 diabetes.
Szendroedi J; Chmelik M; Schmid AI; Nowotny P; Brehm A; Krssak M; Moser E; Roden M
Hepatology; 2009 Oct; 50(4):1079-86. PubMed ID: 19637187
[TBL] [Abstract][Full Text] [Related]
2. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
Rijzewijk LJ; Jonker JT; van der Meer RW; Lubberink M; de Jong HW; Romijn JA; Bax JJ; de Roos A; Heine RJ; Twisk JW; Windhorst AD; Lammertsma AA; Smit JW; Diamant M; Lamb HJ
J Am Coll Cardiol; 2010 Jul; 56(3):225-33. PubMed ID: 20620743
[TBL] [Abstract][Full Text] [Related]
3. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
4. Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus.
Kupriyanova Y; Zaharia OP; Bobrov P; Karusheva Y; Burkart V; Szendroedi J; Hwang JH; Roden M;
J Hepatol; 2021 May; 74(5):1028-1037. PubMed ID: 33259845
[TBL] [Abstract][Full Text] [Related]
5. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.
Szendroedi J; Schmid AI; Chmelik M; Toth C; Brehm A; Krssak M; Nowotny P; Wolzt M; Waldhausl W; Roden M
PLoS Med; 2007 May; 4(5):e154. PubMed ID: 17472434
[TBL] [Abstract][Full Text] [Related]
6. Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients.
Fritsch M; Koliaki C; Livingstone R; Phielix E; Bierwagen A; Meisinger M; Jelenik T; Strassburger K; Zimmermann S; Brockmann K; Wolff C; Hwang JH; Szendroedi J; Roden M
Am J Clin Nutr; 2015 Nov; 102(5):1051-8. PubMed ID: 26423389
[TBL] [Abstract][Full Text] [Related]
7. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.
Schmid AI; Szendroedi J; Chmelik M; Krssák M; Moser E; Roden M
Diabetes Care; 2011 Feb; 34(2):448-53. PubMed ID: 21216854
[TBL] [Abstract][Full Text] [Related]
8. Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes.
Gancheva S; Bierwagen A; Kaul K; Herder C; Nowotny P; Kahl S; Giani G; Klueppelholz B; Knebel B; Begovatz P; Strassburger K; Al-Hasani H; Lundbom J; Szendroedi J; Roden M;
Diabetes; 2016 Jul; 65(7):1849-57. PubMed ID: 27207512
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
[TBL] [Abstract][Full Text] [Related]
10. Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes.
Brouwers B; Schrauwen-Hinderling VB; Jelenik T; Gemmink A; Havekes B; Bruls Y; Dahlmans D; Roden M; Hesselink MKC; Schrauwen P
Clin Sci (Lond); 2017 Aug; 131(15):1905-1917. PubMed ID: 28620012
[TBL] [Abstract][Full Text] [Related]
11. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
12. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.
Koliaki C; Roden M
Mol Cell Endocrinol; 2013 Oct; 379(1-2):35-42. PubMed ID: 23770462
[TBL] [Abstract][Full Text] [Related]
13. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial).
Bacchi E; Negri C; Targher G; Faccioli N; Lanza M; Zoppini G; Zanolin E; Schena F; Bonora E; Moghetti P
Hepatology; 2013 Oct; 58(4):1287-95. PubMed ID: 23504926
[TBL] [Abstract][Full Text] [Related]
14. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring.
Anderwald C; Pfeiler G; Nowotny P; Anderwald-Stadler M; Krebs M; Bischof MG; Kozakova M; Luger A; Pacini G; Roden M; Waldhäusl W
Eur J Clin Invest; 2008 Apr; 38(4):227-37. PubMed ID: 18339003
[TBL] [Abstract][Full Text] [Related]
15. Metabolic characteristics of soleus muscle in relation to insulin action in the offspring of hypertensive parents.
Kratochvílová S; Vyhnanovská P; Vlasáková Z; Hájek M; Skibová J; Pelikánová T
Metabolism; 2006 Oct; 55(10):1388-96. PubMed ID: 16979411
[TBL] [Abstract][Full Text] [Related]
16. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver.
Perseghin G; Lattuada G; De Cobelli F; Esposito A; Belloni E; Ntali G; Ragogna F; Canu T; Scifo P; Del Maschio A; Luzi L
Hepatology; 2008 Jan; 47(1):51-8. PubMed ID: 17955548
[TBL] [Abstract][Full Text] [Related]
17. Amino Acid and Fatty Acid Levels Affect Hepatic Phosphorus Metabolite Content in Metabolically Healthy Humans.
Kahl S; Nowotny B; Strassburger K; Bierwagen A; Klüppelholz B; Hoffmann B; Giani G; Nowotny PJ; Wallscheid F; Hatziagelaki E; Pacini G; Hwang JH; Roden M
J Clin Endocrinol Metab; 2018 Feb; 103(2):460-468. PubMed ID: 29140513
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance of protein metabolism in type 2 diabetes.
Pereira S; Marliss EB; Morais JA; Chevalier S; Gougeon R
Diabetes; 2008 Jan; 57(1):56-63. PubMed ID: 17940118
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.
Thamer C; Tschritter O; Haap M; Shirkavand F; Machann J; Fritsche A; Schick F; Häring H; Stumvoll M
Horm Metab Res; 2005 Apr; 37(4):246-51. PubMed ID: 15952086
[TBL] [Abstract][Full Text] [Related]
20. Reduced skeletal muscle phosphocreatine concentration in type 2 diabetic patients: a quantitative image-based phosphorus-31 MR spectroscopy study.
Ripley EM; Clarke GD; Hamidi V; Martinez RA; Settles FD; Solis C; Deng S; Abdul-Ghani M; Tripathy D; DeFronzo RA
Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E229-E239. PubMed ID: 29509433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
